Conavi Medical Corp. (CNVI : TSX-V)
Common Stock
$0.24
CAD
+0.01 (4.35%)
Last updated: 2026-06-24
CNVI
Conavi Medical Corp.
WealthAwesomePerformance
1 Day
+4.35%
1 Week
+9.09%
1 Month
-11.11%
YTD
-45.45%
Key Statistics
Market Cap
$23.80M
52W High
$0.70
52W Low
$0.22
P/E Ratio
-
50 Day MA
$0.32
200 Day MA
$0.45
Beta
-
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/24/2026 | $0.24 | $0.24 | $0.24 | $0.24 | $0.24 | 11,062 |
| 6/23/2026 | $0.23 | $0.23 | $0.23 | $0.23 | $0.23 | 2,100 |
| 6/22/2026 | $0.24 | $0.24 | $0.23 | $0.23 | $0.23 | 21,647 |
| 6/19/2026 | $0.23 | $0.23 | $0.23 | $0.23 | $0.23 | 1,550 |
| 6/18/2026 | $0.24 | $0.24 | $0.23 | $0.23 | $0.23 | 33,128 |
| 6/17/2026 | $0.25 | $0.25 | $0.22 | $0.22 | $0.22 | 94,233 |
| 6/16/2026 | $0.26 | $0.26 | $0.26 | $0.26 | $0.26 | 8,756 |
| 6/15/2026 | $0.25 | $0.26 | $0.25 | $0.26 | $0.26 | 25,137 |
| 6/12/2026 | $0.23 | $0.24 | $0.23 | $0.24 | $0.24 | 9,120 |
| 6/11/2026 | $0.26 | $0.26 | $0.24 | $0.24 | $0.24 | 4,120 |
Analyst Price Targets
Based on analyst covering CNVI
Wall Street analysts forecast CNVI stock price to rise 316.7% over the next 12 months.
Consensus
No RatingAvg. Target
C$1.00
+316.7% Upside
Current Price
C$0.24
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CNVI's historical volatility
30-Day Vol
89.0%
Annualized
90-Day Vol
76.5%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.20
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.23 | C$0.17 โ C$0.31 |
| 60 trading days | C$0.21 | C$0.14 โ C$0.33 |
| 90 trading days | C$0.20 | C$0.12 โ C$0.34 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Conavi Medical Corp.
Conavi Medical Corp. focuses on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures. It offers Novasight Hybrid System, a system that combines intravascular ultrasound and optical coherence tomography to enable simultaneous and co-registered imaging of coronary arteries. Conavi Medical Corp. is based in Toronto, Canada.
Financials
- Revenue (TTM)
- $778,000
- EBITDA
- $-19.01M
- Profit Margin
- 0.00%
- ROE (TTM)
- 0.00%
- EPS (Diluted)
- -0.20
- Book Value
- -0.14
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About CNVI
Articles Featuring CNVI.V
Latest articles and analysis covering CNVI.V
